MH

Manja Hermina Maria Boerman Elisabeth

Active Director Director DIN 10655368
DIN 10655368 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Manja Hermina Maria Boerman Elisabeth

Data last updated:

Manja Hermina Maria Boerman Elisabeth is a Director at Syngene International Limited (since 2024). The company operates in Pharma. Syngene International Limited reported revenue of ₹3,714 Cr (FY 2025).

DIN 10655368
Primary Designation Director
Industry Pharma
First Appointment 04 Jun 2024
Oldest Company Age 32 yrs
Largest company Syngene International Limited · ₹3,714 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Syngene International Limited L85110KA1993PLC014937
Director04 Jun 20241993₹3,714 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Syngene International Limited
Premium access

Shareholding and investment profile for Manja Hermina Maria Boerman Elisabeth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manja Hermina Maria Boerman Elisabeth

Manja Hermina Maria Boerman Elisabeth currently holds 1 directorship: Syngene International Limited (Director, since 04 Jun 2024, revenue ₹3,714 Cr (FY 2025)).

Manja Hermina Maria Boerman Elisabeth was first appointed on 04 Jun 2024 as Director at Syngene International Limited.

The current boards of Manja Hermina Maria Boerman Elisabeth's companies include Arun Suresh Chandavarkar (Syngene International Limited), Catherine Patricia Rosenberg (Syngene International Limited), Chethan Yogesh (Syngene International Limited), Deepak Jain (Syngene International Limited), Kiran Mazumdar Shaw (Syngene International Limited), Nilanjan Roy (Syngene International Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available